Teva, Antares Receives FDA Approval For Needle-Free Injector

Anonymous User | Login

Teva, Antares Receives FDA Approval For Needle-Free Injector

Published: 29-Jun-2009

First product approval stemming from portfolio of product collaborations batween Teva and Antares

Teva and its partner, Antares have received approval of a Supplemental New Drug Application (sNDA), which added needle-free injection to its Tev-Tropin, human growth hormone (hGH) drug label.

Teva would market the Antares needle-free injector as the Tev-Tropin Tjet Injector system.

Larry Downey, Head of North America Brand Pharmaceuticals division at Teva, said: We are pleased to add this new technology to our growing portfolio through our successful partnership with Antares and to offer patients a less invasive delivery system.”

Paul Wotton, President and CEO of Antares, said: This is the first product approval stemming from our portfolio of product collaborations with Teva and is a very exciting milestone for the company. We look forward to the launch of this product by Teva.

US States Join Medicaid’s Lawsuits Against Wyeth

The US Justice Department has joined forces with 16 states in a legal fight against Wyeth, alleging that the drug maker has failed to reimburse hundreds of millions of do ...

Bristol-Myers Posts Net Earnings Of $638 Million In Q1 2009

Bristol-Myers Squibb Company (Bristol-Myers), an in vitro diagnostics company, has reported net sales of $5.01 billion for the first quarter of 2009, compared with the ne ...

Abbott Reports Net Earnings Of $1.4 Billion For Q1 2009

Abbott Laboratories (Abbott), a US-based health care company, has reported net sales of $6.7 billion for the first quarter of 2009, down 0.7%, compared with the net sales ...

Bristol-Myers Squibb Announces Executive Changes

Bristol-Myers Squibb Company (Bristol-Myers), a in vitro diagnostics company, announced organizational changes. Lamberto Andreotti, Elliott Sigal, and Jean-Marc Huet will ...

Bristol-Myers Elects New President, COO

Bristol-Myers Squibb Company (Bristol-Myers), a in vitro diagnostics company, has elected Lamberto Andreotti to the company as president and chief operating officer (COO) ...

Merck To Release Tredaptive In Mexico, Germany, UK

Merck & Co., has revealed its plans to roll out Tredaptive (ER niacin/laropiprant) in Mexico, Germany and the UK, by the third quarter of the year. Tredaptive, also calle ...

Xyntha' Sales Exceed BDI Pharma’s Q1 Projections

BDI Pharma, a wholesaler of biopharmaceutical products, has posted strong growth in sales of Wyeth’s XYNTHA Antihemophilic Factor (Recombinant) for the first quarter of 2 ...

KineMed Enters Into Collaboration With Bristol-Myers Squibb

KineMed, a translational and personalized medicine development company, has entered into a two year collaboration agreement with Bristol-Myers Squibb in the area of Alzhe ...

Phase I Trial On Compound Developed From AMRI, Bristol-Myers Squibb Collaboration

AMRI has announced that Bristol-Myers Squibb has submitted a Clinical Trial Application (CTA) to the Medical Products Agency (MPA) in Sweden for approval to initiate Phas ...

Schering Plough Wins Marketing Approval For Sycrest

Sycrest tablets to treat schizophrenia and manic episodes associated with bipolar I disorder. ...

Network Sites

Contract Research Clinical Trials Contract Services Drug Delivery Drug Discovery & Development OTC Regulatory Affairs Process and Production IT and Software Laboratory Instrumentation Manufacturing Fine & Specialty Chemicals Medical Devices Business Review Inward Investment Packaging

Mail sent successfully

Tell your friend about this article

Please enter a valid email address

Please enter your name

Please enter the mail body

Your Name: *

Your Email: *

Friend's Email: *

Email Body: *: I thought you would be interested in this article : http://www.pharmaceutical-business-review.com/news/teva_antares_receives_fda_approval_for_needlefree_injector_090629/

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

World Courier

Offering Fully-Integrated GxP-Compliant Global Transport and Storage for the Pharmaceutical Industry...

WebWise Learning

Turning Information into Working Knowledge ...

Vetter Pharma International

High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...

Valsynthese

Hazardous Chemistry in Safe Hands ...

USB

Products from Affymetrix ...

Umicore Precious Metals Chemistry

Chemicals and Catalysts for Industrial Applications ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Using the Mean Kinetic Temperature (MKT) As a Parameter to Determine Whether Perishable Goods Have Been Transported and Stored Correctly

Tecnosoft systems use MKT calculation to control the acquired values and report the user w ...

USB HotStart-IT for Real Time PCR

USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...

Related Companies

Schering-Plough Corporation

Schering-Plough Corporation (Schering-Plough) is a pharmaceutical company focused on di ...

Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited (Teva), a global pharmaceutical company, is enga ...

Merck & Co., Inc.

Merck & Co., Inc. (Merck) is a global research-driven pharmaceutical company engaged in ...

Abbott Laboratories

Abbott Laboratories (Abbott) is a global health care company. It is principally engaged ...

Wyeth

Wyeth is engaged in developing and providing pharmaceuticals and healthcare products fo ...

Suppliers Product News

World Courier CTSCS Depots Provide Dedicated Storage for GMO Products

In response to growing client demand and based on recently-established international biosafety regulations, World Courier has begun rolling out dedicated storage areas for GMO-derived pharmaceutical products throughout its global investigational drug storage network.

World Courier Triples Clinical Trial Storage Capacity Worldwide with Two New Facilities and Client-Driven Expansion

World Courier expands its GMP-compliant Clinical Trial Supply Chain Services (CTSCS) network, facilitating access to growing pharmaceutical markets in Africa and Australia.

World Courier Achieves Coveted GxP-Compliant Status Worldwide with Focus on GDP, Quality Management

With a fully GxP-compliant transport and supply chain system in place, World Courier meets the most demanding industry requirements for managing time- and temperature-sensitive clinical trial materials used in global studies.

Vetter Dedicates New Facility in Suburban Chicago

The new facility will enable collaboration very early in development process

Pharma Supplier Vetter Shares Pride in Consistent Growth and International Success with Distinguished Visitor Minister zu Guttenberg

Economics and Technology Minister visits global leader's headquarters in southern Germany.

Vetter Packages Success with New Facility

Vetter's new secondary packaging operation allows the company to double its production in half the time.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750